Complete Response of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-Associated Renal Cell Carcinoma to Pembrolizumab Immunotherapy: A Case Report

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a rare autosomal dominant disorder that results from a germline mutation in the fumarate hydratase (FH) gene; it manifests as cutaneous leiomyomas, uterine fibroids, and renal cell cancer (RCC). Patients with HLRCC-associated RCC (HLRCC-RCC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tao, Huang, Yan, Huang, Xing, Lv, Zheng, Tian, Shuo, Ma, Xin, Zhang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554149/
https://www.ncbi.nlm.nih.gov/pubmed/34722283
http://dx.doi.org/10.3389/fonc.2021.735077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8554149/
https://www.ncbi.nlm.nih.gov/pubmed/34722283
http://dx.doi.org/10.3389/fonc.2021.735077

Ejemplares similares